Annotation Detail for CYP3A5
Basic Information Top
Gene Symbol: | CYP3A5 ( CP35,CYPIIIA5,DKFZp686L16231,FLJ31317,P450PCN3,PCN3 ) |
---|---|
Gene Full Name: | cytochrome P450, family 3, subfamily A, polypeptide 5 |
Band: | 7q22.1 |
Quick Links | Entrez ID:1577; OMIM: 605325; Uniprot ID:CP3A5_HUMAN; ENSEMBL ID: ENSG00000106258; HGNC ID: 2638 |
Relate to Another Database: | SFARIGene; denovo-db |
No data |
Pathway ID | Pathway Name |
---|---|
hsa00830 | Retinol metabolism |
hsa00140 | Steroid hormone biosynthesis |
hsa00980 | Metabolism of xenobiotics by cytochrome P450 |
hsa00982 | Drug metabolism - cytochrome P450 |
hsa00983 | Drug metabolism - other enzymes |
hsa01100 | Metabolic pathways |
hsa00591 | Linoleic acid metabolism |
Pathway ID | Pathway Name |
---|---|
Biological oxidations |
No data |
No data |
Pathway ID | Pathway Name |
---|---|
500197 | Xenobiotics |
No data |
No data |
Desease Name |
---|
hypercholesterolemia |
cholesterol |
oral cancer |
lung transplant complications |
NORMALVARIATION |
blood pressure, arterial |
CARDIOVASCULAR |
liver cancer |
cholesterol, LDL |
prostate cancer |
nephropathy |
muscle damage |
CANCER |
PHARMACOGENOMIC |
kidney transplant |
RENAL |
breast cancer |
thyroid cancer |
IMMUNE |
aflatoxin-albumin |
METABOLIC |
ABT-773 plasma levels |
lung cancer |
cyclosporine pharmacokinetics |
cervical cancer |
No data |
Desease Name |
---|
Hypertension, salt-sensitive essential, susceptibility to |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C035342 | 1,4-naphthoquinone | CYP3A5 protein results in increased abundance of 1,4-naphthoquinone | increases abundance | 16243959 |
C112765 | 17-(allylamino)-17-demethoxygeldanamycin | CYP3A5 protein affects the metabolism of 17-(allylamino)-17-demethoxygeldanamycin | affects metabolic processing | 15718306 |
C029350 | 1-naphthol | CYP3A5 protein results in increased abundance of 1-naphthol | increases abundance | 16243959 |
C038345 | 3-hydroxytamoxifen | 3-hydroxytamoxifen results in decreased activity of CYP3A5 protein | decreases activity | 12419016 |
C028657 | 3-methoxymorphinan | CYP3A5 protein affects the chemical synthesis of 3-methoxymorphinan | affects chemical synthesis | 15988119 |
C016601 | 4-hydroxytamoxifen | 4-hydroxytamoxifen results in decreased activity of CYP3A5 protein | decreases activity | 12419016 |
D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of CYP3A5 protein | affects expression | 20106945 |
D016604 | Aflatoxin B1 | CYP3A5 protein results in increased activity of Aflatoxin B1 | increases activity | 15454734 |
C027955 | aflatoxin G1 | CYP3A5 protein results in increased susceptibility to aflatoxin G1 | increases response to substance | 11189750 |
D015760 | Alfentanil | CYB5 protein promotes the reaction [CYP3A5 protein affects the metabolism of Alfentanil] | affects metabolic processing|increases reaction | 15557344 |
D015760 | Alfentanil | CYP3A5 protein affects the metabolism of Alfentanil | affects metabolic processing | 15731592 15557344 |
D015760 | Alfentanil | Ketoconazole inhibits the reaction [CYP3A5 protein affects the metabolism of Alfentanil] | affects metabolic processing|decreases reaction | 15731592 |
D015760 | Alfentanil | Troleandomycin inhibits the reaction [CYP3A5 protein affects the metabolism of Alfentanil] | affects metabolic processing|decreases reaction | 15731592 |
D000525 | Alprazolam | CYP3A5 protein results in increased hydroxylation of Alprazolam | increases hydroxylation | 15903124 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CYP3A5 mRNA | increases expression | 20106945 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CYP3A5 mRNA | decreases expression | 20018196 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CYP3A5 mRNA | increases expression | 19150397 |
D002065 | Buspirone | CYP3A5 protein results in increased oxidation of Buspirone | increases oxidation | 15640381 |
D002220 | Carbamazepine | Carbamazepine results in increased expression of CYP3A5 mRNA | increases expression | 12673034 |
C035038 | carbosulfan | CYP3A5 protein results in increased metabolism of carbosulfan | increases metabolic processing | 20307514 |
C088453 | Celsior | Celsior results in decreased expression of CYP3A5 mRNA | decreases expression | 15448115 |
D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP3A5 mRNA | increases expression | 17851650 |
D004390 | Chlorpyrifos | Chlorpyrifos results in increased expression of CYP3A5 mRNA | increases expression | 16757081 |
D004390 | Chlorpyrifos | CYP3A5 protein affects the metabolism of Chlorpyrifos | affects metabolic processing | 17079358 17110060 |
C010087 | cineole | CYP3A5 protein results in increased hydroxylation of cineole | increases hydroxylation | 15715982 |
D002990 | Clobetasol | Clobetasol results in increased expression of CYP3A5 mRNA | increases expression | 16882163 |
D003022 | Clotrimazole | Clotrimazole results in increased expression of CYP3A5 protein | increases expression | 8632764 |
D003345 | Corticosterone | Corticosterone results in increased metabolism of CYP3A5 protein | increases metabolic processing | 20032461 |
C059483 | CQA 206-291 | CYP3A5 protein results in increased metabolism of CQA 206-291 | increases metabolic processing | 1346997 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of CYP3A5 mRNA | decreases expression | 20106945 |
D016572 | Cyclosporine | Cyclosporine results in increased expression of CYP3A5 mRNA | increases expression | 12673034 |
D016572 | Cyclosporine | CYP3A5 protein affects the metabolism of Cyclosporine | affects metabolic processing | 15964336 15454731 15808586 15450954 |
D016572 | Cyclosporine | CYP3A5 protein polymorphism affects the metabolism of Cyclosporine | affects metabolic processing | 15808586 |
C064445 | dechloroethylcyclophosphamide | CYP3A5 protein affects the chemical synthesis of dechloroethylcyclophosphamide | affects chemical synthesis | 15875221 |
D003671 | DEET | CYP3A5 protein results in increased metabolism of DEET | increases metabolic processing | 11854147 |
D003687 | Dehydroepiandrosterone | CYP3A5 protein results in increased hydroxylation of Dehydroepiandrosterone | increases hydroxylation | 15845858 |
D003907 | Dexamethasone | Dexamethasone results in increased expression of CYP3A5 mRNA | increases expression | 10696073 |
D003917 | Dextrorphan | CYP3A5 protein affects the metabolism of Dextrorphan | affects metabolic processing | 15988119 |
D003976 | Diazinon | Diazinon results in increased expression of CYP3A5 mRNA | increases expression | 16757081 |
D002117 | Calcitriol | Calcitriol results in increased expression of CYP3A5 mRNA | increases expression | 16002434 |
D004110 | Diltiazem | CYP3A5 protein affects the metabolism of Diltiazem | affects metabolic processing | 16024008 |
D004110 | Diltiazem | CYP3A5 protein polymorphism affects the metabolism of Diltiazem | affects metabolic processing | 16024008 |
D004110 | Diltiazem | CYP3A5 protein results in decreased methylation of Diltiazem | decreases methylation | 15499178 |
D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide affects the expression of CYP3A5 mRNA | affects expression | 12843640 |
D004726 | Endosulfan | CYP3A5 protein affects the metabolism of Endosulfan | affects metabolic processing | 16581944 |
D004917 | Erythromycin | CYP3A5 protein results in decreased methylation of Erythromycin | decreases methylation | 15383492 |
D004997 | Ethinyl Estradiol | CYP3A5 protein results in increased hydroxylation of Ethinyl Estradiol | increases hydroxylation | 15304426 |
D005047 | Etoposide | CYP3A5 gene polymorphism affects the susceptibility to Etoposide | affects response to substance | 12969965 |
D005047 | Etoposide | CYP3A5 protein results in decreased methylation of Etoposide | decreases methylation | 8114683 |
D005284 | Fenthion | CYP3A5 protein affects the metabolism of Fenthion | affects metabolic processing | 17110060 |
D005445 | Flunitrazepam | CYP3A5 protein results in increased hydroxylation of Flunitrazepam | increases hydroxylation | 15383492 |
D005473 | Fluoxetine | Fluoxetine inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol] | decreases reaction|increases activity|increases oxidation | 12584149 |
D016666 | Fluvoxamine | Fluvoxamine inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol] | decreases reaction|increases activity|increases oxidation | 12584149 |
C419708 | gefitinib | CYP3A5 protein affects the metabolism of gefitinib | affects metabolic processing | 15788367 |
D006220 | Haloperidol | CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol | increases activity|increases oxidation | 12584149 |
D006220 | Haloperidol | Fluoxetine inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol] | decreases reaction|increases activity|increases oxidation | 12584149 |
D006220 | Haloperidol | Fluvoxamine inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol] | decreases reaction|increases activity|increases oxidation | 12584149 |
D006220 | Haloperidol | nefazodone inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol] | decreases reaction|increases activity|increases oxidation | 12584149 |
D006220 | Haloperidol | norfluoxetine inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol] | decreases reaction|increases activity|increases oxidation | 12584149 |
D006220 | Haloperidol | Trazodone inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol] | decreases reaction|increases activity|increases oxidation | 12584149 |
D007069 | Ifosfamide | CYP3A5 protein affects the metabolism of Ifosfamide | affects metabolic processing | 15875221 |
D007069 | Ifosfamide | CYP3A5 protein results in decreased ethylation of Ifosfamide | decreases ethylation | 15821045 |
C051890 | irinotecan | [selenomethylselenocysteine co-treated with irinotecan] results in increased expression of CYP3A5 | affects cotreatment|increases expression | 15897249 |
C051890 | irinotecan | CYP3A5 protein results in increased metabolism of irinotecan | increases metabolic processing | 16271446 |
D007654 | Ketoconazole | Ketoconazole inhibits the reaction [CYP3A5 protein affects the metabolism of Alfentanil] | affects metabolic processing|decreases reaction | 15731592 |
D007654 | Ketoconazole | Ketoconazole results in decreased activity of CYP3A5 protein | decreases activity | 15557344 |
D008012 | Lidocaine | CYP3A5 protein results in decreased methylation of Lidocaine | decreases methylation | 15383492 |
D008294 | Malathion | CYP3A5 protein affects the metabolism of Malathion | affects metabolic processing | 17110060 |
D003915 | Dextromethorphan | CYP3A5 protein affects the metabolism of Dextromethorphan | affects metabolic processing | 15988119 |
D003915 | Dextromethorphan | CYP3A5 protein results in decreased methylation of Dextromethorphan | decreases methylation | 15383492 |
D003915 | Dextromethorphan | CYP3A5 protein results in increased oxidation of Dextromethorphan | increases oxidation | 15383492 |
D008874 | Midazolam | CYP3A5 protein affects the metabolism of Midazolam | affects metabolic processing | 15801540 |
D008874 | Midazolam | CYP3A5 gene polymorphism affects the metabolism of Midazolam | affects metabolic processing | 15900284 |
D008874 | Midazolam | CYP3A5 protein affects the metabolism of Midazolam | affects metabolic processing | 15801540 15900284 19557931 |
D008874 | Midazolam | CYP3A5 protein results in increased hydroxylation of Midazolam | increases hydroxylation | 15499178 15383492 |
D008874 | Midazolam | shengmaisan affects the reaction [CYP3A5 protein affects the metabolism of Midazolam] | affects metabolic processing|affects reaction | 19557931 |
D008874 | Midazolam | CYP3A5 protein affects the metabolism of Midazolam | affects metabolic processing | 15801540 |
D009173 | Mycophenolic Acid | CYP3A5 protein results in increased methylation of Mycophenolic Acid | increases methylation | 15570183 |
C028787 | N-desmethyltamoxifen | N-desmethyltamoxifen results in decreased activity of CYP3A5 protein | decreases activity | 12419016 |
C051752 | nefazodone | nefazodone inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol] | decreases reaction|increases activity|increases oxidation | 12584149 |
D019888 | Nelfinavir | Nelfinavir results in decreased activity of CYP3A5 protein | decreases activity | 15523003 |
C454678 | N-ethyl-3-toluamide | CYP3A5 protein results in increased chemical synthesis of N-ethyl-3-toluamide | increases chemical synthesis | 11854147 |
C036139 | norfluoxetine | norfluoxetine inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol] | decreases reaction|increases activity|increases oxidation | 12584149 |
C016904 | norverapamil | norverapamil results in decreased activity of CYP3A5 protein | decreases activity | 15689501 |
C025589 | ochratoxin A | CYP3A5 protein results in increased susceptibility to ochratoxin A | increases response to substance | 11189750 |
D010278 | Parathion | CYP3A5 protein affects the metabolism of Parathion | affects metabolic processing | 12669189 17110060 17079358 |
D026023 | Permethrin | Permethrin results in increased expression of CYP3A5 mRNA | increases expression | 19326768 |
D010622 | Phencyclidine | CYP3A5 protein affects the metabolism of Phencyclidine | affects metabolic processing | 16782764 |
D010634 | Phenobarbital | Phenobarbital results in increased expression of CYP3A5 mRNA | increases expression | 15629111 10696073 |
D010672 | Phenytoin | Phenytoin results in increased expression of CYP3A5 mRNA | increases expression | 12673034 |
C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CYP3A5 mRNA | affects binding|increases activity|increases expression | 19710929 |
D010936 | Plant Extracts | Plant Extracts results in decreased activity of CYP3A5 protein | decreases activity | 15900287 |
D012110 | Reserpine | Reserpine results in increased expression of CYP3A5 protein | increases expression | 8632764 |
D012293 | Rifampin | Rifampin results in increased expression of CYP3A5 mRNA | increases expression | 12040753 15681896 12673034 15629111 |
D019438 | Ritonavir | Ritonavir results in decreased activity of CYP3A5 protein | decreases activity | 15523003 |
C087123 | romidepsin | CYP3A5 protein affects the metabolism of romidepsin | affects metabolic processing | 15635176 |
D012643 | Selenium | Selenium results in decreased expression of CYP3A5 mRNA | decreases expression | 19244175 |
C002979 | selenomethylselenocysteine | [selenomethylselenocysteine co-treated with irinotecan] results in increased expression of CYP3A5 | affects cotreatment|increases expression | 15897249 |
C009252 | shengmaisan | shengmaisan affects the reaction [CYP3A5 protein affects the metabolism of Midazolam] | affects metabolic processing|affects reaction | 19557931 |
D016559 | Tacrolimus | CYP3A5 gene affects the susceptibility to Tacrolimus | affects response to substance | 15723604 |
D016559 | Tacrolimus | CYP3A5 gene polymorphism affects the metabolism of Tacrolimus | affects metabolic processing | 15919447 |
D016559 | Tacrolimus | CYP3A5 gene SNP affects the metabolism of Tacrolimus | affects metabolic processing | 15729180 |
D016559 | Tacrolimus | CYP3A5 protein affects the metabolism of Tacrolimus | affects metabolic processing | 15964336 15808586 15502717 |
D016559 | Tacrolimus | CYP3A5 protein polymorphism affects the metabolism of Tacrolimus | affects metabolic processing | 15502717 15808586 |
D016559 | Tacrolimus | CYP3A5 protein results in decreased methylation of Tacrolimus | decreases methylation | 15951320 |
D013629 | Tamoxifen | CYP3A5 protein affects the metabolism of Tamoxifen | affects metabolic processing | 15596297 |
D013629 | Tamoxifen | CYP3A5 protein polymorphism affects the metabolism of Tamoxifen | affects metabolic processing | 15596297 |
D013629 | Tamoxifen | Tamoxifen results in decreased activity of CYP3A5 protein | decreases activity | 12419016 |
D013713 | Teniposide | CYP3A5 protein results in decreased methylation of Teniposide | decreases methylation | 8114683 |
D016593 | Terfenadine | CYP3A5 protein affects the metabolism of Terfenadine | affects metabolic processing | 15383492 |
D013739 | Testosterone | CYP3A5 protein results in increased hydroxylation of Testosterone | increases hydroxylation | 15876487 15845858 15499178 16012074 15383492 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP3A5 mRNA | increases expression | 20106945 |
D013852 | Thiotepa | CYP3A5 gene SNP affects the export of Thiotepa | affects export | 19076156 |
D013852 | Thiotepa | CYP3A5 protein affects the susceptibility to Thiotepa | affects response to substance | 19076156 |
D014196 | Trazodone | Trazodone inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol] | decreases reaction|increases activity|increases oxidation | 12584149 |
D013721 | Triethylenephosphoramide | CYP3A5 gene SNP affects the export of Triethylenephosphoramide | affects export | 19076156 |
D013721 | Triethylenephosphoramide | CYP3A5 protein affects the susceptibility to Triethylenephosphoramide | affects response to substance | 19076156 |
C057693 | troglitazone | troglitazone results in decreased expression of CYP3A5 | decreases expression | 15618651 |
D014217 | Troleandomycin | Troleandomycin inhibits the reaction [CYP3A5 protein affects the metabolism of Alfentanil] | affects metabolic processing|decreases reaction | 15731592 |
D014217 | Troleandomycin | Troleandomycin results in decreased activity of CYP3A5 protein | decreases activity | 15557344 |
D014217 | Troleandomycin | Troleandomycin results in decreased activity of CYP3A5 | decreases activity | 10910959 |
D014700 | Verapamil | Verapamil results in decreased activity of CYP3A5 protein | decreases activity | 15689501 |
D002762 | Cholecalciferol | CYP3A5 protein results in increased hydroxylation of Cholecalciferol | increases hydroxylation | 16207822 |
D014810 | Vitamin E | Vitamin E results in decreased expression of CYP3A5 mRNA | decreases expression | 19244175 |
D014859 | Warfarin | CYP3A5 gene polymorphism affects the susceptibility to Warfarin | affects response to substance | 19752777 |
D014859 | Warfarin | CYP3A5 protein affects the susceptibility to Warfarin | affects response to substance | 19752777 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 3.73 | 14745880 | |
MESH:D000014 | Abnormalities, Drug-Induced | Carbamazepine | 13.97 | 8986270 | |
MESH:D000014 | Abnormalities, Drug-Induced | Phenobarbital | 13.97 | 6195326 | |
MESH:D000014 | Abnormalities, Drug-Induced | Phenytoin | 13.97 | 9118846 10563481 6195326 9677735 3425630 8986270 | |
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 13.97 | 15322242 11752688 14514962 | |
MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 3.13 | 17505938 | |
MESH:D055371 | Acute Lung Injury | pirinixic acid | 2.38 | 18653653 | |
MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 3.24 | 20127859 20464547 | |
MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 3.24 | 14692618 | |
MESH:D000236 | Adenoma | Benzo(a)pyrene | 2.14 | 6695378 | |
MESH:D018248 | Adenoma, Liver Cell | Phenobarbital | 12.69 | 17620307 | |
MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 12.69 | 16434500 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 12.69 | 16835633 | |
MESH:D000309 | Adrenal Insufficiency | Dehydroepiandrosterone | 4.98 | 17302879 | |
MESH:D000382 | Agricultural Workers' Diseases | Chlorpyrifos | 14.13 | 17119214 11874814 16611668 | |
MESH:D000382 | Agricultural Workers' Diseases | Diazinon | 14.13 | 16487989 | |
MESH:D000382 | Agricultural Workers' Diseases | Malathion | 14.13 | 17119214 11874814 | |
MESH:D000382 | Agricultural Workers' Diseases | Parathion | 14.13 | 17119214 11874814 | |
OMIM:607154 | ALLERGIC RHINITIS | Terfenadine | 4.93 | 16037679 | |
MESH:D000544 | Alzheimer Disease | Plant Extracts | 4.18 | 16962711 | |
MESH:D000544 | Alzheimer Disease | Trazodone | 4.18 | 16856516 17897735 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 2.25 | 11748828 | |
MESH:D000787 | Angina Pectoris | Diltiazem | 5.77 | 15929820 | |
MESH:D000987 | Antisocial Personality Disorder | Testosterone | 5.04 | 7506515 | |
MESH:D001008 | Anxiety Disorders | Fluoxetine | 4.27 | 18083778 | |
MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 3.29 | 19183758 | |
MESH:D001145 | Arrhythmias, Cardiac | Lidocaine | 4.86 | 513065 | |
MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 8.05 | 11256880 | |
MESH:D001161 | Arteriosclerosis | Reserpine | 8.05 | 10729376 | |
MESH:D001169 | Arthritis, Experimental | Dexamethasone | 9.19 | 17659584 | |
MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 9.19 | 15885639 | |
MESH:D001169 | Arthritis, Experimental | Plant Extracts | 9.19 | 14686799 | |
MESH:D050197 | Atherosclerosis | Phenytoin | 3.41 | 15136057 | |
MESH:D001289 | Attention Deficit Disorder with Hyperactivity | Dextromethorphan | 4.76 | 17175572 | |
MESH:D001321 | Autistic Disorder | Buspirone | 2.58 | 18056831 | |
MESH:D001321 | Autistic Disorder | Fluoxetine | 2.58 | 18775368 19232924 | |
MESH:D001321 | Autistic Disorder | Fluvoxamine | 2.58 | 19232924 18775368 12607287 | |
MESH:D001321 | Autistic Disorder | Haloperidol | 2.58 | 19368416 18080171 | |
MESH:D001327 | Autoimmune Diseases | Cholecalciferol | 4.25 | 16142846 | |
MESH:D001714 | Bipolar Disorder | Carbamazepine | 3.66 | 20046352 17594078 | |
MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 6.37 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 6.37 | 12125929 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.98 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 2.20 | 15746008 | |
MESH:D019046 | Bone Marrow Neoplasms | Etoposide | 4.35 | 14601052 | |
MESH:D002545 | Brain Ischemia | Plant Extracts | 3.94 | 16041641 | |
MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 6.56 | 20146248 17474063 | |
MESH:D001943 | Breast Neoplasms | Calcitriol | 6.56 | 11237771 | |
MESH:D001943 | Breast Neoplasms | Etoposide | 6.56 | 16322251 | |
MESH:D001943 | Breast Neoplasms | Malathion | 6.56 | 12762645 | |
MESH:D001943 | Breast Neoplasms | ochratoxin A | 6.56 | 11921183 | |
MESH:D001943 | Breast Neoplasms | Parathion | 6.56 | 12762645 | |
MESH:D001943 | Breast Neoplasms | Reserpine | 6.56 | 11921183 | |
MESH:D001943 | Breast Neoplasms | selenomethylselenocysteine | 6.56 | 18855134 | |
MESH:D001943 | Breast Neoplasms | Tamoxifen | 6.56 | 20005174 20390343 18855134 18821012 18351453 18997820 19011961 20065188 19115204 19066611 15668708 19487384 11161223 17049068 20135344 19244106 18629630 16818667 20544844 17261762 15565566 17440819 19155303 19103187 18984771 17242785 18425577 19410462 16202921 19059307 19142967 21138602 19289846 16273361 18815881 19288272 19200415 19189212 16873071 20859285 19084267 19189210 19221464 21152245 17893378 | |
MESH:D001943 | Breast Neoplasms | Testosterone | 6.56 | 17261762 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 6.56 | 20435547 | |
MESH:D002057 | Burns, Chemical | Plant Extracts | 4.52 | 9625245 | |
MESH:D002252 | Carbon Tetrachloride Poisoning | Vitamin E | 3.16 | 16050911 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 2.15 | 16835633 | |
MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 3.72 | 19066611 | |
MESH:D006528 | Carcinoma, Hepatocellular | Aflatoxin B1 | 5.01 | 21507988 12907637 12619106 | |
MESH:D006528 | Carcinoma, Hepatocellular | Phenobarbital | 5.01 | 1701930 17173139 6705139 20935162 20007298 | |
MESH:D006528 | Carcinoma, Hepatocellular | Plant Extracts | 5.01 | 18834353 | |
MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 5.01 | 16924424 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | gefitinib | 3.61 | 18347146 19233551 20005069 16230376 15496427 17290066 | |
MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 3.64 | 20419170 | |
MESH:D002294 | Carcinoma, Squamous Cell | Calcitriol | 3.64 | 11237771 | |
MESH:D002295 | Carcinoma, Transitional Cell | romidepsin | 7.80 | 17230511 | |
MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 7.80 | 17572228 | |
MESH:D006332 | Cardiomegaly | Plant Extracts | 5.28 | 17645561 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 5.28 | 16120746 18670907 18850075 | |
MESH:D002318 | Cardiovascular Diseases | Tacrolimus | 4.03 | 17703430 | |
MESH:D002340 | Carotid Artery Diseases | shengmaisan | 5.97 | 19557931 | |
MESH:D002375 | Catalepsy | Haloperidol | 4.11 | 15215559 1977408 | |
MESH:D002471 | Cell Transformation, Neoplastic | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 4.60 | 20889678 | |
MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 4.60 | 12371664 | |
MESH:D002493 | Central Nervous System Diseases | Phenobarbital | 9.08 | 4080065 | |
MESH:D002493 | Central Nervous System Diseases | Phenytoin | 9.08 | 4080065 | |
MESH:D002543 | Cerebral Hemorrhage | Warfarin | 5.08 | 11061249 | |
MESH:D002637 | Chest Pain | Trazodone | 5.21 | 15238202 | |
MESH:D002653 | Child Behavior Disorders | Dextromethorphan | 6.42 | 17175572 | |
MESH:D002659 | Child Development Disorders, Pervasive | Testosterone | 3.32 | 20678186 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 2.47 | 16835633 | |
MESH:D002779 | Cholestasis | Cyclosporine | 9.71 | 19486331 | |
MESH:D002779 | Cholestasis | Ethinyl Estradiol | 9.71 | 17110522 16919318 17681005 16105132 15861022 17333356 11677210 | |
MESH:D002779 | Cholestasis | pirinixic acid | 9.71 | 19176532 | |
OMIM:601042 | CHOREOATHETOSIS/SPASTICITY, EPISODIC | Phenytoin | 5.07 | 11748493 | |
MESH:D002971 | Cleft Lip | Phenytoin | 3.67 | 2227380 | |
MESH:D002972 | Cleft Palate | Phenytoin | 4.77 | 2227380 6862529 1687470 3877104 6856622 10789828 | |
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 4.77 | 15668235 15340226 16354765 12621046 8697196 | |
MESH:D003092 | Colitis | Selenium | 3.01 | 17936198 | |
MESH:D003103 | Coloboma | Phenytoin | 4.42 | 9212184 | |
MESH:D003110 | Colonic Neoplasms | 17-(allylamino)-17-demethoxygeldanamycin | 4.82 | 15993848 | |
MESH:D003110 | Colonic Neoplasms | Dexamethasone | 4.82 | 15824018 | |
MESH:D003110 | Colonic Neoplasms | irinotecan | 4.82 | 17287894 17725105 | |
MESH:D015179 | Colorectal Neoplasms | gefitinib | 2.91 | 17594712 | |
MESH:D015179 | Colorectal Neoplasms | irinotecan | 2.91 | 16303861 16391804 17454858 17159606 15273666 18259882 18509181 | |
MESH:D003128 | Coma | Trazodone | 5.32 | 10836866 | |
MESH:D000013 | Congenital Abnormalities | Phenytoin | 7.09 | 10627286 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 7.09 | 17141729 14669216 | |
MESH:D023903 | Coronary Restenosis | Warfarin | 4.91 | 12872399 | |
MESH:D003371 | Cough | Dextromethorphan | 5.33 | 17323712 | |
OMIM:122700 | COUMARIN RESISTANCE | Warfarin | 5.07 | 20579077 20497562 | |
MESH:D019465 | Craniofacial Abnormalities | Carbamazepine | 9.47 | 9014606 | |
MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 9.47 | 17728286 | |
MESH:D019465 | Craniofacial Abnormalities | ochratoxin A | 9.47 | 20036863 | |
MESH:D019465 | Craniofacial Abnormalities | Permethrin | 9.47 | 19861644 | |
MESH:D019465 | Craniofacial Abnormalities | Phenytoin | 9.47 | 19952982 8986270 9212184 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 9.47 | 10048152 20055451 15322242 | |
MESH:D019465 | Craniofacial Abnormalities | Vitamin E | 9.47 | 19769572 | |
MESH:D003490 | Cyanosis | Endosulfan | 4.76 | 7900959 | |
MESH:D016757 | Death, Sudden, Cardiac | Haloperidol | 4.10 | 20210726 | |
MESH:D003704 | Dementia | Haloperidol | 8.19 | 11575062 | |
MESH:D003704 | Dementia | Trazodone | 8.19 | 11575062 12587811 | |
MESH:D003711 | Demyelinating Diseases | Tamoxifen | 3.58 | 19031437 | |
MESH:D003866 | Depressive Disorder | Fluoxetine | 13.69 | 15014590 | |
MESH:D003866 | Depressive Disorder | Fluvoxamine | 13.69 | 19571598 | |
MESH:D003866 | Depressive Disorder | nefazodone | 13.69 | 18083778 16410371 | |
MESH:D003866 | Depressive Disorder | Trazodone | 13.69 | 15014590 18083778 20305041 3378227 19623435 4066620 3690436 | |
MESH:D003865 | Depressive Disorder, Major | Fluvoxamine | 8.80 | 17474826 | |
MESH:D003865 | Depressive Disorder, Major | Trazodone | 8.80 | 16968574 | |
MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 2.69 | 12438553 | |
MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 1.99 | 18249437 | |
MESH:D003877 | Dermatitis, Contact | Permethrin | 4.25 | 14617103 | |
MESH:D018500 | Diabetes Insipidus, Nephrogenic | 17-(allylamino)-17-demethoxygeldanamycin | 5.46 | 18854434 | |
MESH:D003922 | Diabetes Mellitus, Type 1 | Dehydroepiandrosterone | 5.29 | 16616286 | |
MESH:D003922 | Diabetes Mellitus, Type 1 | Warfarin | 5.29 | 18772604 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 3.80 | 17107852 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | troglitazone | 3.80 | 16023994 | |
MESH:D003925 | Diabetic Angiopathies | troglitazone | 4.86 | 12601628 | |
MESH:D003928 | Diabetic Nephropathies | Plant Extracts | 11.33 | 19706694 | |
MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 11.33 | 19279558 | |
MESH:D003928 | Diabetic Nephropathies | Warfarin | 11.33 | 12644472 | |
MESH:D003967 | Diarrhea | Dexamethasone | 2.97 | 7237001 | |
OMIM:607208 | DRAVET SYNDROME | Carbamazepine | 9.81 | 11748493 | |
OMIM:607208 | DRAVET SYNDROME | Phenytoin | 9.81 | 11748493 | |
MESH:D003875 | Drug Eruptions | Phenytoin | 10.38 | 15024534 | |
MESH:D003875 | Drug Eruptions | Warfarin | 10.38 | 14723717 | |
MESH:D004342 | Drug Hypersensitivity | Carbamazepine | 3.86 | 16538175 20216337 15057820 16538176 | |
MESH:D056486 | Drug-Induced Liver Injury | Carbamazepine | 13.62 | 17465707 | |
MESH:D056486 | Drug-Induced Liver Injury | Chlorodiphenyl (54% Chlorine) | 13.62 | 17851650 | |
MESH:D056486 | Drug-Induced Liver Injury | Ketoconazole | 13.62 | 18289764 | |
MESH:D056486 | Drug-Induced Liver Injury | Ritonavir | 13.62 | 14986274 | |
MESH:D056486 | Drug-Induced Liver Injury | Selenium | 13.62 | 15131321 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 13.62 | 20420201 | |
MESH:D056486 | Drug-Induced Liver Injury | troglitazone | 13.62 | 14986274 | |
MESH:D004362 | Drug Toxicity | Carbamazepine | 6.31 | 20216337 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 6.31 | 11462148 | |
MESH:D004381 | Duodenal Ulcer | Tacrolimus | 4.39 | 17202747 | |
MESH:D004409 | Dyskinesia, Drug-Induced | Trazodone | 5.12 | 3690436 | |
MESH:D004417 | Dyspnea | Diazinon | 8.23 | 16487989 | |
MESH:D004417 | Dyspnea | Endosulfan | 8.23 | 7900959 3388749 | |
MESH:D004421 | Dystonia | Phenobarbital | 8.55 | 1851702 | |
MESH:D004421 | Dystonia | Trazodone | 8.55 | 3700695 | |
MESH:C538011 | Eales disease | Vitamin E | 3.89 | 9068938 | |
MESH:D004485 | Eczema | Dexamethasone | 3.70 | 12438553 | |
MESH:D004487 | Edema | Dexamethasone | 17.87 | 19703484 | |
MESH:D004487 | Edema | Fluoxetine | 17.87 | 12798668 | |
MESH:D004487 | Edema | pirinixic acid | 17.87 | 12083418 | |
MESH:D004487 | Edema | Plant Extracts | 17.87 | 12787963 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 17.87 | 11000095 12711302 | |
MESH:D004487 | Edema | Trazodone | 17.87 | 12798668 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 3.09 | 16714409 18230668 15322242 | |
MESH:D004646 | Emphysema | Endosulfan | 5.74 | 7900959 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Calcitriol | 20.77 | 15138306 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Carbamazepine | 20.77 | 17654737 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 20.77 | 12538720 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Phenytoin | 20.77 | 17654737 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 20.77 | 19031437 | |
MESH:D018159 | Endolymphatic Hydrops | Dimethyl Sulfoxide | 5.74 | 20641076 | |
MESH:D016889 | Endometrial Neoplasms | 4-hydroxytamoxifen | 5.90 | 19148513 | |
MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 5.90 | 19155303 16202921 17893378 20544844 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 2.32 | 9294722 10568697 | |
MESH:D004719 | Endomyocardial Fibrosis | Plant Extracts | 4.87 | 15268973 | |
MESH:D004816 | Epidermal Necrolysis, Toxic | Carbamazepine | 9.19 | 18855540 16538176 16415921 19915237 20485159 | |
MESH:D004816 | Epidermal Necrolysis, Toxic | Phenytoin | 9.19 | 20235791 | |
MESH:D004820 | Epidermolysis Bullosa | Phenytoin | 5.42 | 1399206 6251365 | |
MESH:D004831 | Epilepsies, Myoclonic | Carbamazepine | 8.59 | 17275665 | |
MESH:D004831 | Epilepsies, Myoclonic | Phenobarbital | 8.59 | 3659116 | |
MESH:D004828 | Epilepsies, Partial | Carbamazepine | 12.43 | 17116037 16628512 15008574 | |
MESH:D004828 | Epilepsies, Partial | Phenobarbital | 12.43 | 11558140 3922381 | |
MESH:D004828 | Epilepsies, Partial | Phenytoin | 12.43 | 11558140 17116037 | |
MESH:D004827 | Epilepsy | Carbamazepine | 11.87 | 9014606 17465707 19700373 821787 19620853 20417680 19439326 7988514 17178248 18234410 | |
MESH:D004827 | Epilepsy | Phenobarbital | 11.87 | 20417680 | |
MESH:D004827 | Epilepsy | Phenytoin | 11.87 | 821787 20417680 11434505 | |
MESH:D004827 | Epilepsy | Plant Extracts | 11.87 | 19439326 19700373 | |
MESH:D004832 | Epilepsy, Absence | Phenobarbital | 2.86 | 6401628 | |
MESH:D017029 | Epilepsy, Complex Partial | Carbamazepine | 15.06 | 7750514 | |
MESH:D017029 | Epilepsy, Complex Partial | Phenobarbital | 15.06 | 7750514 | |
MESH:D017029 | Epilepsy, Complex Partial | Phenytoin | 15.06 | 7750514 | |
MESH:D004830 | Epilepsy, Tonic-Clonic | Carbamazepine | 13.43 | 15276670 3659116 | |
MESH:D004830 | Epilepsy, Tonic-Clonic | Phenobarbital | 13.43 | 3659116 | |
MESH:D004830 | Epilepsy, Tonic-Clonic | Phenytoin | 13.43 | 3659116 | |
MESH:D007172 | Erectile Dysfunction | Trazodone | 4.72 | 7604472 | |
MESH:D004916 | Erythromelalgia | Carbamazepine | 4.92 | 19549232 | |
MESH:D004938 | Esophageal Neoplasms | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 3.39 | 20426865 | |
MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 3.39 | 16530937 | |
MESH:D020329 | Essential Tremor | Trazodone | 5.31 | 3296121 | |
MESH:D005076 | Exanthema | Carbamazepine | 4.67 | 20485159 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 2.38 | 11564622 | |
MESH:D005198 | Fanconi Syndrome | Ifosfamide | 5.79 | 17481685 | |
MESH:D005234 | Fatty Liver | Cyclosporine | 17.07 | 19224547 | |
MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 17.07 | 15345470 | |
MESH:D005234 | Fatty Liver | pirinixic acid | 17.07 | 19236843 20131406 | |
MESH:D005234 | Fatty Liver | Plant Extracts | 17.07 | 15975614 | |
MESH:D005234 | Fatty Liver | Tamoxifen | 17.07 | 19224547 14986274 | |
MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 2.69 | 16709447 | |
MESH:D005313 | Fetal Death | Phenytoin | 8.15 | 10627286 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 8.15 | 11858732 | |
MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 3.73 | 14745880 | |
MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 3.38 | 19069698 | |
MESH:D005355 | Fibrosis | Cyclosporine | 5.92 | 12168785 12639820 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 5.92 | 20067830 | |
MESH:D005391 | Firesetting Behavior | Testosterone | 5.04 | 7506515 | |
MESH:D005499 | Folliculitis | Clobetasol | 6.55 | 1671328 | |
MESH:D006471 | Gastrointestinal Hemorrhage | Warfarin | 5.90 | 11794436 | |
MESH:D005776 | Gaucher Disease | Warfarin | 5.19 | 12359135 | |
MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 10.26 | 8708960 | |
MESH:D005885 | Gingival Hyperplasia | Phenytoin | 10.26 | 9029455 | |
MESH:D019214 | Gingival Overgrowth | Phenytoin | 5.42 | 16390469 14659971 | |
MESH:D005909 | Glioblastoma | Testosterone | 3.49 | 17162496 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.78 | 10696789 | |
MESH:D006086 | Graft vs Host Disease | Tacrolimus | 5.09 | 16376943 | |
MESH:D006130 | Growth Disorders | Tacrolimus | 4.35 | 11041285 | |
MESH:D034381 | Hearing Loss | Dimethyl Sulfoxide | 4.48 | 20641076 | |
MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 8.23 | 20471113 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 8.23 | 10048152 11294989 | |
MESH:D006330 | Heart Defects, Congenital | Vitamin E | 8.23 | 16080930 | |
MESH:D006333 | Heart Failure | pirinixic acid | 8.68 | 20558911 | |
MESH:D006333 | Heart Failure | Plant Extracts | 8.68 | 18097624 | |
MESH:D006333 | Heart Failure | Selenium | 8.68 | 17162251 | |
MESH:D006406 | Hematoma | Warfarin | 5.90 | 17493413 | |
MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 3.62 | 15720958 | |
MESH:D006470 | Hemorrhage | Endosulfan | 13.32 | 7900959 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 13.32 | 11000095 | |
MESH:D006470 | Hemorrhage | Warfarin | 13.32 | 18429757 | |
MESH:D006505 | Hepatitis | Diazinon | 3.82 | 16487989 | |
MESH:D006529 | Hepatomegaly | Phenobarbital | 9.91 | 16109766 | |
MESH:D006529 | Hepatomegaly | pirinixic acid | 9.91 | 18467677 16221962 19772884 19176532 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 9.91 | 16120746 15340226 12621046 | |
MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 4.75 | 7520565 | |
MESH:D006548 | Hernia, Diaphragmatic | Vitamin E | 4.75 | 16490937 16863852 | |
MESH:D006561 | Herpes Simplex | Etoposide | 7.63 | 10809021 | |
MESH:D006561 | Herpes Simplex | Plant Extracts | 7.63 | 10715843 | |
MESH:D006628 | Hirsutism | Testosterone | 4.84 | 17019078 | |
MESH:D015658 | HIV Infections | Nelfinavir | 8.49 | 11362904 15388451 | |
MESH:D015658 | HIV Infections | Plant Extracts | 8.49 | 12878215 | |
MESH:D015658 | HIV Infections | Ritonavir | 8.49 | 15388451 11363243 17378895 11141242 | |
MESH:D006689 | Hodgkin Disease | Etoposide | 6.11 | 15147373 17606976 18180244 16200630 16135485 | |
MESH:D006689 | Hodgkin Disease | Ifosfamide | 6.11 | 16135485 | |
MESH:D019584 | Hot Flashes | Fluoxetine | 17.91 | 14716179 | |
MESH:D019584 | Hot Flashes | Plant Extracts | 17.91 | 16566672 14716179 17454163 | |
MESH:D019584 | Hot Flashes | Trazodone | 17.91 | 19711746 | |
MESH:D019584 | Hot Flashes | Vitamin E | 17.91 | 14716179 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 3.23 | 16354765 8697196 18606429 15340226 16959395 | |
MESH:D006930 | Hyperalgesia | Trazodone | 4.23 | 12790215 | |
MESH:D017588 | Hyperandrogenism | Testosterone | 4.49 | 17019078 | |
MESH:D006943 | Hyperglycemia | pirinixic acid | 2.48 | 20558911 | |
MESH:D020138 | Hyperhomocysteinemia | Carbamazepine | 11.75 | 10459572 | |
MESH:D020138 | Hyperhomocysteinemia | Phenytoin | 11.75 | 10459572 | |
MESH:D020138 | Hyperhomocysteinemia | Plant Extracts | 11.75 | 16484555 | |
MESH:D006949 | Hyperlipidemias | Plant Extracts | 3.74 | 15975614 15268973 | |
MESH:D006965 | Hyperplasia | Carbamazepine | 4.43 | 18773962 | |
MESH:D006967 | Hypersensitivity | Terfenadine | 4.54 | 2570798 | |
MESH:D006973 | Hypertension | Cyclosporine | 9.21 | 10903974 | |
MESH:D006973 | Hypertension | Dexamethasone | 9.21 | 17042910 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 9.21 | 18670907 18850075 | |
MESH:D006973 | Hypertension | Verapamil | 9.21 | 17700361 | |
OMIM:145500 | HYPERTENSION, ESSENTIAL | marker/mechanism | |||
MESH:D006976 | Hypertension, Pulmonary | gefitinib | 7.01 | 18424623 | |
MESH:D006976 | Hypertension, Pulmonary | Warfarin | 7.01 | 12359135 | |
MESH:D017380 | Hypertrophy, Right Ventricular | gefitinib | 5.43 | 18424623 | |
MESH:D007006 | Hypogonadism | Testosterone | 3.98 | 12002444 | |
MESH:C537153 | Hypomagnesemia primary | Tacrolimus | 5.35 | 11041285 | |
MESH:D007018 | Hypopituitarism | Testosterone | 5.38 | 17426086 | |
MESH:D007021 | Hypospadias | Ethinyl Estradiol | 3.03 | 16945680 16569931 | |
MESH:D007022 | Hypotension | Tacrolimus | 4.38 | 11041285 | |
MESH:D007024 | Hypotension, Orthostatic | Trazodone | 5.21 | 15811171 | |
MESH:D007035 | Hypothermia | Reserpine | 5.51 | 1977408 | |
MESH:D007174 | Impulse Control Disorders | Testosterone | 5.04 | 7506515 | |
MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 2.72 | 12013081 | |
MESH:D007248 | Infertility, Male | Diazinon | 11.45 | 12948887 16466525 | |
MESH:D007248 | Infertility, Male | Endosulfan | 11.45 | 9432128 8588293 | |
MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 11.45 | 17937319 | |
MESH:D007248 | Infertility, Male | Parathion | 11.45 | 16029889 | |
MESH:D007249 | Inflammation | Dexamethasone | 16.79 | 11099482 8960868 | |
MESH:D007249 | Inflammation | Erythromycin | 16.79 | 19502290 | |
MESH:D007249 | Inflammation | Fluoxetine | 16.79 | 12798668 | |
MESH:D007249 | Inflammation | Plant Extracts | 16.79 | 16366677 12787963 15997105 19332304 | |
MESH:D007249 | Inflammation | Tamoxifen | 16.79 | 19457130 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 16.79 | 12878042 12200463 | |
MESH:D007249 | Inflammation | Trazodone | 16.79 | 12798668 | |
MESH:D007251 | Influenza, Human | Selenium | 8.26 | 16624496 | |
MESH:D007251 | Influenza, Human | Vitamin E | 8.26 | 16624496 | |
MESH:D007299 | Insect Bites and Stings | Permethrin | 5.01 | 12971516 12749493 15189238 | |
MESH:D007333 | Insulin Resistance | pirinixic acid | 2.07 | 16306350 | |
MESH:D007414 | Intestinal Neoplasms | Plant Extracts | 3.91 | 12584176 12351151 12628509 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 2.61 | 16580747 | |
MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 3.63 | 15604871 | |
MESH:D007674 | Kidney Diseases | Cyclosporine | 13.59 | 18776723 10903974 8314463 | |
MESH:D007674 | Kidney Diseases | Ifosfamide | 13.59 | 17035713 16221203 | |
MESH:D007674 | Kidney Diseases | ochratoxin A | 13.59 | 11409539 | |
MESH:D007674 | Kidney Diseases | Tacrolimus | 13.59 | 11041285 | |
MESH:D007674 | Kidney Diseases | Vitamin E | 13.59 | 12488133 | |
MESH:D007676 | Kidney Failure, Chronic | Selenium | 3.16 | 16518626 | |
MESH:D007680 | Kidney Neoplasms | Cyclosporine | 12.44 | 12371664 | |
MESH:D007680 | Kidney Neoplasms | gefitinib | 12.44 | 18625569 | |
MESH:D007680 | Kidney Neoplasms | ochratoxin A | 12.44 | 16251485 | |
MESH:D007680 | Kidney Neoplasms | Tamoxifen | 12.44 | 18625569 | |
MESH:D007859 | Learning Disorders | Endosulfan | 4.33 | 8157075 | |
MESH:D016773 | Leishmaniasis, Cutaneous | Ketoconazole | 4.03 | 2166429 19744259 8889330 1311351 | |
MESH:D007898 | Leishmaniasis, Visceral | Ketoconazole | 3.92 | 11332679 | |
MESH:D007938 | Leukemia | Permethrin | 3.67 | 12937054 | |
MESH:D004915 | Leukemia, Erythroblastic, Acute | troglitazone | 5.33 | 16085563 | |
MESH:D007945 | Leukemia, Lymphoid | Thiotepa | 5.48 | 10069464 | |
MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Ritonavir | 4.78 | 16174765 | |
MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Thiotepa | 4.58 | 10373061 | |
MESH:D007951 | Leukemia, Myeloid | Thiotepa | 4.81 | 10069464 | |
MESH:D008064 | Lipidoses | Fluoxetine | 9.92 | 17567588 15342952 | |
MESH:D008064 | Lipidoses | Ketoconazole | 9.92 | 17567588 | |
MESH:D008064 | Lipidoses | Tamoxifen | 9.92 | 17567588 15342952 | |
MESH:D054068 | Livedo Reticularis | Warfarin | 5.90 | 18280355 | |
MESH:D008103 | Liver Cirrhosis | Phenobarbital | 5.29 | 21047994 | |
MESH:D008103 | Liver Cirrhosis | Plant Extracts | 5.29 | 17157831 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 8.40 | 16718785 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Dimethyl Sulfoxide | 8.40 | 11682029 | |
MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 8.40 | 15474484 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Plant Extracts | 8.40 | 15479170 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 8.40 | 18564211 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 8.40 | 12878042 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Vitamin E | 8.40 | 16169303 | |
MESH:D008107 | Liver Diseases | Chlorpyrifos | 7.08 | 15991261 | |
MESH:D008107 | Liver Diseases | Phenobarbital | 7.08 | 19363144 | |
MESH:D008107 | Liver Diseases | Phenytoin | 7.08 | 14986274 | |
MESH:D008107 | Liver Diseases | Plant Extracts | 7.08 | 17034775 | |
MESH:D017114 | Liver Failure, Acute | Trazodone | 4.70 | 19857765 | |
MESH:D008113 | Liver Neoplasms | Aflatoxin B1 | 19.03 | 18177683 2125692 9163691 15890375 | |
MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 19.03 | 20195826 21137059 | |
MESH:D008113 | Liver Neoplasms | Dehydroepiandrosterone | 19.03 | 18709148 | |
MESH:D008113 | Liver Neoplasms | Phenobarbital | 19.03 | 8742319 19812893 19073162 15975961 21047994 19482888 | |
MESH:D008113 | Liver Neoplasms | pirinixic acid | 19.03 | 15890375 20007298 16377806 | |
MESH:D008113 | Liver Neoplasms | Plant Extracts | 19.03 | 19168119 | |
MESH:D008113 | Liver Neoplasms | Tamoxifen | 19.03 | 16684651 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 19.03 | 16984957 | |
MESH:D008114 | Liver Neoplasms, Experimental | Aflatoxin B1 | 9.64 | 8603461 | |
MESH:D008114 | Liver Neoplasms, Experimental | Dehydroepiandrosterone | 9.64 | 8603461 | |
MESH:D008114 | Liver Neoplasms, Experimental | Phenobarbital | 9.64 | 18308698 1399818 2563599 6150874 17172636 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 9.64 | 12151625 | |
MESH:D008133 | Long QT Syndrome | Terfenadine | 7.21 | 8772706 | |
MESH:D008133 | Long QT Syndrome | Trazodone | 7.21 | 18167038 | |
MESH:D008171 | Lung Diseases | Vitamin E | 2.60 | 16863852 | |
MESH:D008175 | Lung Neoplasms | Aflatoxin B1 | 8.21 | 14755239 | |
MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 8.21 | 20464547 6695378 18816296 18520028 18569708 20135361 20064080 17053015 20869020 | |
MESH:D008175 | Lung Neoplasms | Dexamethasone | 8.21 | 15824018 11195469 | |
MESH:D008175 | Lung Neoplasms | Plant Extracts | 8.21 | 20869020 | |
MESH:D008175 | Lung Neoplasms | Tamoxifen | 8.21 | 18625569 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 8.21 | 19555203 11884234 | |
MESH:D008175 | Lung Neoplasms | Vitamin E | 8.21 | 11062179 | |
MESH:D008178 | Lupus Erythematosus, Cutaneous | Rifampin | 5.33 | 11422169 | |
MESH:D008180 | Lupus Erythematosus, Systemic | Carbamazepine | 5.11 | 16628512 | |
MESH:D008180 | Lupus Erythematosus, Systemic | Rifampin | 5.11 | 11422169 | |
MESH:D008223 | Lymphoma | Etoposide | 6.44 | 12854902 12556972 | |
MESH:D008223 | Lymphoma | Thiotepa | 6.44 | 10069464 | |
MESH:D017728 | Lymphoma, Large-Cell, Anaplastic | 17-(allylamino)-17-demethoxygeldanamycin | 5.81 | 17157164 | |
MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 2.97 | 19428831 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Corticosterone | 23.66 | 12807724 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Dehydroepiandrosterone | 23.66 | 16457693 | |
MESH:D008325 | Mammary Neoplasms, Experimental | gefitinib | 23.66 | 18375820 | |
MESH:D008325 | Mammary Neoplasms, Experimental | ochratoxin A | 23.66 | 11921183 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Reserpine | 23.66 | 11921183 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 23.66 | 15318939 | |
MESH:D008325 | Mammary Neoplasms, Experimental | selenomethylselenocysteine | 23.66 | 15318939 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 23.66 | 19196723 19196722 16827153 14580682 11731420 | |
MESH:D020149 | Manganese Poisoning | Tamoxifen | 3.73 | 19453300 | |
MESH:D008545 | Melanoma | Tamoxifen | 1.76 | 19393235 12393984 | |
MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 3.38 | 15990972 | |
MESH:D001523 | Mental Disorders | Fluoxetine | 16.30 | 16856516 | |
MESH:D001523 | Mental Disorders | Fluvoxamine | 16.30 | 16856516 | |
MESH:D001523 | Mental Disorders | Haloperidol | 16.30 | 16856516 | |
MESH:D001523 | Mental Disorders | norfluoxetine | 16.30 | 16856516 | |
MESH:D001523 | Mental Disorders | Trazodone | 16.30 | 16856516 | |
MESH:D008607 | Mental Retardation | Carbamazepine | 5.34 | 9014606 | |
MESH:D008607 | Mental Retardation | Phenytoin | 5.34 | 9212184 | |
MESH:D008654 | Mesothelioma | Selenium | 2.40 | 15107826 | |
MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 3.97 | 16801185 | |
MESH:D008708 | Methemoglobinemia | Lidocaine | 4.87 | 3537620 | |
MESH:D008850 | Microphthalmos | ochratoxin A | 5.03 | 20036863 | |
MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 2.55 | 16381670 | |
MESH:D009069 | Movement Disorders | Trazodone | 5.02 | 4066620 | |
MESH:D052016 | Mucositis | irinotecan | 4.21 | 17159606 | |
MESH:D009101 | Multiple Myeloma | Dexamethasone | 2.91 | 16118317 15867202 15744524 | |
MESH:D009135 | Muscular Diseases | pirinixic acid | 2.73 | 16239165 | |
MESH:D009164 | Mycobacterium Infections | Rifampin | 9.03 | 18474467 | |
MESH:D009164 | Mycobacterium Infections | Ritonavir | 9.03 | 21442799 | |
MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 3.02 | 9809623 | |
MESH:D009203 | Myocardial Infarction | pirinixic acid | 1.75 | 19151258 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 2.36 | 12213967 | |
MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 2.31 | 16411023 | |
MESH:D009205 | Myocarditis | shengmaisan | 6.29 | 19557931 | |
MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenobarbital | 9.84 | 17484760 | |
MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenytoin | 9.84 | 17484760 | |
MESH:D009207 | Myoclonus | Fluoxetine | 5.08 | 8041377 | |
MESH:D009224 | Myotonia Congenita | Carbamazepine | 9.83 | 20399394 | |
MESH:D009224 | Myotonia Congenita | Phenytoin | 9.83 | 1896199 | |
MESH:D009336 | Necrosis | Warfarin | 4.75 | 14723717 | |
MESH:D009362 | Neoplasm Metastasis | irinotecan | 4.61 | 18259882 | |
MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 4.61 | 19393235 | |
MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 2.18 | 19410462 | |
MESH:D009369 | Neoplasms | Benzo(a)pyrene | 5.74 | 11141357 | |
MESH:D009369 | Neoplasms | pirinixic acid | 5.74 | 17405874 | |
MESH:D009369 | Neoplasms | Thiotepa | 5.74 | 18854779 | |
MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 3.19 | 19200415 19196722 19189210 | |
MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 3.63 | 17954296 | |
MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 2.60 | 18481113 19348381 | |
MESH:D009421 | Nervous System Malformations | Carbamazepine | 7.40 | 16990009 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 7.40 | 14600291 | |
MESH:D009436 | Neural Tube Defects | ochratoxin A | 6.28 | 20036863 | |
MESH:D009436 | Neural Tube Defects | Phenytoin | 6.28 | 9118846 | |
MESH:D019954 | Neurobehavioral Manifestations | Plant Extracts | 4.40 | 17168769 | |
MESH:D009447 | Neuroblastoma | irinotecan | 6.09 | 8761367 | |
MESH:D009447 | Neuroblastoma | Thiotepa | 6.09 | 8761367 | |
MESH:D019636 | Neurodegenerative Diseases | Tacrolimus | 4.28 | 15081597 | |
MESH:D017599 | Neuroectodermal Tumors | irinotecan | 9.30 | 8761367 | |
MESH:D017599 | Neuroectodermal Tumors | Thiotepa | 9.30 | 12837982 8761367 | |
MESH:D020258 | Neurotoxicity Syndromes | Chlorpyrifos | 6.85 | 15081274 | |
MESH:D020258 | Neurotoxicity Syndromes | Malathion | 6.85 | 15081274 | |
MESH:D009503 | Neutropenia | Ritonavir | 4.64 | 17378895 | |
MESH:D009765 | Obesity | pirinixic acid | 3.81 | 20558911 | |
MESH:D009765 | Obesity | Plant Extracts | 3.81 | 20132043 19056576 | |
MESH:D009771 | Obsessive-Compulsive Disorder | Fluoxetine | 4.71 | 20418887 | |
MESH:D053578 | Opsoclonus-Myoclonus Syndrome | Trazodone | 5.65 | 1318289 | |
MESH:D010018 | Osteomalacia | Carbamazepine | 15.73 | 17016548 | |
MESH:D010018 | Osteomalacia | Phenobarbital | 15.73 | 17016548 | |
MESH:D010018 | Osteomalacia | Phenytoin | 15.73 | 17016548 | |
MESH:D015663 | Osteoporosis, Postmenopausal | Dehydroepiandrosterone | 4.29 | 16397352 | |
MESH:D010146 | Pain | Carbamazepine | 14.33 | 15215642 | |
MESH:D010146 | Pain | Fluoxetine | 14.33 | 12798668 | |
MESH:D010146 | Pain | Lidocaine | 14.33 | 15215642 | |
MESH:D010146 | Pain | Phenytoin | 14.33 | 15215642 | |
MESH:D010146 | Pain | Trazodone | 14.33 | 12790215 12798668 | |
MESH:D010190 | Pancreatic Neoplasms | Etoposide | 4.34 | 19003803 | |
MESH:D010190 | Pancreatic Neoplasms | Phenobarbital | 4.34 | 16965848 | |
MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.94 | 11578682 | |
MESH:D010212 | Papilloma | Plant Extracts | 3.72 | 16517061 15173996 | |
MESH:D010267 | Parapsoriasis | Carbamazepine | 4.92 | 16538176 | |
MESH:D010302 | Parkinson Disease, Secondary | Trazodone | 4.96 | 3378227 | |
OMIM:167400 | PAROXYSMAL EXTREME PAIN DISORDER | Carbamazepine | 5.12 | 17145499 17679678 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 3.43 | 12520081 | |
MESH:D020774 | Pick Disease of the Brain | Fluoxetine | 5.22 | 8041377 | |
MESH:D010954 | Plasmacytoma | Selenium | 4.07 | 15087411 | |
MESH:D011041 | Poisoning | Diazinon | 3.62 | 17603234 | |
MESH:D017689 | Polydactyly | Phenytoin | 4.35 | 9212184 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 2.80 | 18163543 | |
MESH:D011230 | Precancerous Conditions | Cyclosporine | 6.68 | 12371664 | |
MESH:D011230 | Precancerous Conditions | Phenobarbital | 6.68 | 2563599 | |
MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 3.04 | 21297632 | |
MESH:D011248 | Pregnancy Complications | Carbamazepine | 4.37 | 9014606 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Carbamazepine | 7.22 | 9014606 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 7.22 | 11222880 11896295 11399792 11118676 | |
MESH:D011470 | Prostatic Hyperplasia | Calcitriol | 3.98 | 15572423 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | Testosterone | 4.33 | 20887781 | |
MESH:D011471 | Prostatic Neoplasms | marker/mechanism | 18306354 | ||
MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 2.48 | 17292933 | |
MESH:D011471 | Prostatic Neoplasms | Calcitriol | 2.48 | 16289102 15754350 12479363 18247401 16644109 | |
MESH:D011471 | Prostatic Neoplasms | Cholecalciferol | 2.48 | 17024972 | |
MESH:D011471 | Prostatic Neoplasms | Etoposide | 2.48 | 17172428 | |
MESH:D011471 | Prostatic Neoplasms | gefitinib | 2.48 | 17914592 15651060 16685379 | |
MESH:D011471 | Prostatic Neoplasms | Ketoconazole | 2.48 | 17404083 | |
MESH:D011471 | Prostatic Neoplasms | Plant Extracts | 2.48 | 14666653 17804756 | |
MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 2.48 | 15067354 | |
MESH:D011471 | Prostatic Neoplasms | Vitamin E | 2.48 | 15084515 | |
MESH:D020151 | Protein C Deficiency | Warfarin | 5.55 | 18376272 | |
MESH:D011537 | Pruritus | Ethinyl Estradiol | 2.53 | 15861022 16919318 | |
MESH:D019310 | Pseudolymphoma | Carbamazepine | 16.62 | 12752131 9591791 | |
MESH:D019310 | Pseudolymphoma | Phenobarbital | 16.62 | 12752131 | |
MESH:D019310 | Pseudolymphoma | Phenytoin | 16.62 | 1419762 8603615 12752131 | |
MESH:D011565 | Psoriasis | Cyclosporine | 1.88 | 16882103 | |
MESH:D011595 | Psychomotor Agitation | Haloperidol | 4.17 | 11575062 | |
MESH:D011618 | Psychotic Disorders | Haloperidol | 3.64 | 11575062 | |
MESH:D011655 | Pulmonary Embolism | Warfarin | 5.55 | 19300499 | |
MESH:D011657 | Pulmonary Eosinophilia | Trazodone | 5.32 | 8520792 | |
MESH:D011658 | Pulmonary Fibrosis | gefitinib | 5.32 | 18424623 | |
MESH:D011658 | Pulmonary Fibrosis | troglitazone | 5.32 | 18162602 | |
MESH:D015427 | Reperfusion Injury | pirinixic acid | 1.93 | 19058328 | |
MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 3.28 | 18379247 11700416 | |
MESH:D012131 | Respiratory Insufficiency | Trazodone | 5.02 | 8520792 | |
MESH:D012135 | Respiratory Sounds | Chlorpyrifos | 12.04 | 11874814 17119214 16611668 | |
MESH:D012135 | Respiratory Sounds | Malathion | 12.04 | 17119214 11874814 | |
MESH:D012135 | Respiratory Sounds | Parathion | 12.04 | 17119214 11874814 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 3.07 | 18990726 | |
MESH:D012140 | Respiratory Tract Diseases | Chlorpyrifos | 13.41 | 16611668 17119214 | |
MESH:D012140 | Respiratory Tract Diseases | Malathion | 13.41 | 17119214 | |
MESH:D012140 | Respiratory Tract Diseases | Parathion | 13.41 | 17119214 | |
MESH:D012221 | Rhinitis, Allergic, Perennial | Terfenadine | 5.10 | 8201490 | |
MESH:D012509 | Sarcoma | Ifosfamide | 4.94 | 15625365 18313854 17710206 | |
MESH:D012512 | Sarcoma, Ewing's | Etoposide | 3.94 | 14601052 | |
MESH:D012559 | Schizophrenia | Haloperidol | 3.83 | 19369910 18513383 1830565 20107430 | |
MESH:D012559 | Schizophrenia | Trazodone | 3.83 | 7868106 | |
MESH:D012640 | Seizures | Carbamazepine | 12.49 | 16938433 9046859 19414003 16876388 15946322 9844417 16180713 | |
MESH:D012640 | Seizures | Endosulfan | 12.49 | 10698677 7539098 | |
MESH:D012640 | Seizures | Midazolam | 12.49 | 10087439 | |
MESH:D012640 | Seizures | Phenobarbital | 12.49 | 3137016 16876388 11442880 4039156 | |
MESH:D012640 | Seizures | Phenytoin | 12.49 | 16876388 15946322 3691417 11044598 9844417 3137016 19919933 10029267 | |
MESH:D003294 | Seizures, Febrile | Phenobarbital | 4.02 | 6407741 | |
MESH:D020230 | Serotonin Syndrome | Fluoxetine | 10.59 | 8704074 | |
MESH:D020230 | Serotonin Syndrome | Trazodone | 10.59 | 9050436 8704074 7854515 | |
MESH:D012729 | Sex Chromosome Aberrations | Chlorpyrifos | 5.27 | 6418539 | |
MESH:D012735 | Sexual Dysfunction, Physiological | Testosterone | 5.38 | 16631401 | |
MESH:D012851 | Sinus Thrombosis, Intracranial | Warfarin | 5.09 | 12269725 | |
MESH:D012871 | Skin Diseases | Vitamin E | 2.18 | 18709164 | |
MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 6.86 | 19755658 10029692 | |
MESH:D012878 | Skin Neoplasms | Plant Extracts | 6.86 | 16517061 15173996 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 6.86 | 16192470 | |
MESH:D012892 | Sleep Deprivation | Trazodone | 5.45 | 19798453 | |
MESH:D012893 | Sleep Disorders | Carbamazepine | 13.78 | 19414003 | |
MESH:D012893 | Sleep Disorders | Midazolam | 13.78 | 6138072 | |
MESH:D012893 | Sleep Disorders | Trazodone | 13.78 | 19395429 | |
MESH:D007319 | Sleep Initiation and Maintenance Disorders | Alprazolam | 12.59 | 15341891 | |
MESH:D007319 | Sleep Initiation and Maintenance Disorders | Midazolam | 12.59 | 6138071 | |
MESH:D007319 | Sleep Initiation and Maintenance Disorders | Trazodone | 12.59 | 17225163 15341891 15062207 | |
MESH:D012983 | Soft Tissue Neoplasms | Ifosfamide | 5.44 | 15625365 | |
MESH:D013088 | Spermatocele | Ethinyl Estradiol | 8.86 | 16709447 | |
MESH:D013088 | Spermatocele | Tamoxifen | 8.86 | 16709447 | |
MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 3.24 | 19457130 | |
MESH:D013262 | Stevens-Johnson Syndrome | Carbamazepine | 8.98 | 16538176 20485159 19915237 16415921 19694795 18855540 15057820 | |
MESH:D013262 | Stevens-Johnson Syndrome | Phenytoin | 8.98 | 20235791 | |
MESH:D013272 | Stomach Diseases | Dexamethasone | 3.53 | 15472012 | |
MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 2.93 | 2093021 20155912 | |
MESH:D013274 | Stomach Neoplasms | irinotecan | 2.93 | 15723263 | |
MESH:D013274 | Stomach Neoplasms | troglitazone | 2.93 | 15930296 | |
MESH:D013276 | Stomach Ulcer | Dexamethasone | 5.34 | 15138204 | |
MESH:D013276 | Stomach Ulcer | Plant Extracts | 5.34 | 15255614 17135157 18237397 18193104 12787963 | |
MESH:D020521 | Stroke | Trazodone | 10.97 | 810300 | |
MESH:D020521 | Stroke | Vitamin E | 10.97 | 16517955 | |
MESH:D020521 | Stroke | Warfarin | 10.97 | 19300499 | |
MESH:D013375 | Substance Withdrawal Syndrome | Trazodone | 4.70 | 393279 12749364 | |
MESH:D015173 | Supratentorial Neoplasms | Thiotepa | 5.37 | 12837982 | |
MESH:D017180 | Tachycardia, Ventricular | Haloperidol | 8.51 | 20210726 | |
MESH:D017180 | Tachycardia, Ventricular | Trazodone | 8.51 | 2424891 | |
MESH:D013705 | Temporomandibular Joint Disorders | Plant Extracts | 4.66 | 17997062 | |
MESH:D013742 | Tetanus | Midazolam | 5.82 | 2903605 | |
MESH:D013923 | Thromboembolism | Warfarin | 5.35 | 18698879 16960144 | |
MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 8.55 | 11994571 | |
MESH:D019851 | Thrombophilia | Warfarin | 8.55 | 17493413 | |
MESH:D013927 | Thrombosis | Ethinyl Estradiol | 7.13 | 15669648 | |
MESH:D013927 | Thrombosis | Warfarin | 7.13 | 15720958 17245631 19300499 11518727 11307788 17672075 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 3.09 | 12697716 | |
MESH:D013964 | Thyroid Neoplasms | gefitinib | 5.63 | 16940797 | |
MESH:D013964 | Thyroid Neoplasms | Phenobarbital | 5.63 | 1399818 | |
MESH:D016171 | Torsades de Pointes | Terfenadine | 4.90 | 8256756 | |
MESH:D014376 | Tuberculosis | Rifampin | 4.22 | 18397238 15236969 | |
MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 3.70 | 17053015 | |
MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 3.70 | 17572228 8653321 16712894 | |
MESH:D014570 | Urologic Diseases | Diazinon | 4.46 | 16487989 | |
MESH:D014581 | Urticaria | Terfenadine | 4.55 | 2569995 2565098 2568013 2885854 2859714 | |
MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 2.54 | 14692618 | |
MESH:D014605 | Uveitis | Cyclosporine | 9.07 | 1336536 | |
MESH:D014605 | Uveitis | Dexamethasone | 9.07 | 1336536 | |
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.78 | 12125929 | |
MESH:D014657 | Vasculitis | Warfarin | 5.09 | 20337814 | |
MESH:D054556 | Venous Thromboembolism | Warfarin | 5.55 | 18776969 | |
MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 8.33 | 15869587 14671159 | |
MESH:D020246 | Venous Thrombosis | Warfarin | 8.33 | 14723717 15733061 | |
MESH:D018487 | Ventricular Dysfunction, Left | Plant Extracts | 3.97 | 18097624 | |
MESH:D018879 | Ventricular Premature Complexes | Trazodone | 6.01 | 2424891 | |
MESH:D020257 | Ventricular Remodeling | Plant Extracts | 4.52 | 18097624 | |
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 3.43 | 15886252 | |
MESH:D014947 | Wounds and Injuries | Plant Extracts | 3.59 | 19894650 20213670 | |
MESH:D014985 | Xerophthalmia | Cyclosporine | 3.63 | 17120751 |
Pathway ID | Pathway Name |
---|---|
REACT:13433 | Biological oxidations |
KEGG:00982 | Drug metabolism - cytochrome P450 |
KEGG:00983 | Drug metabolism - other enzymes |
KEGG:00591 | Linoleic acid metabolism |
KEGG:01100 | Metabolic pathways |
KEGG:00980 | Metabolism of xenobiotics by cytochrome P450 |
KEGG:00830 | Retinol metabolism |
KEGG:00140 | Steroid hormone biosynthesis |
Releated gene ID | Related gene Name |
---|---|
PA124 | CYP2C19 |
PA131 | CYP3A5 |
PA378 | NR1I2 |
Releated disease ID | Related disease Name |
---|---|
PA444760 | Leukemia, Myeloid, Acute |
PA443560 | Breast Neoplasms |
PA445062 | Neoplasms |
PA443937 | Drug Toxicity |
PA446661 | Carcinoma, Small Cell |
PA443626 | Carcinoma, Squamous Cell |
PA444682 | Kidney Diseases |
PA445113 | Neutropenia |
PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
PA444761 | Leukemia, Myeloid |
PA447178 | Pulmonary Disease, Chronic Obstructive |
PA134850491 | Transplantation |
PA446213 | HIV Infections |
PA444997 | Muscular Diseases |
PA447216 | Schizophrenia |
PA446116 | Inflammatory Bowel Diseases |
PA444552 | Hypertension |
PA444101 | Esophageal Neoplasms |
PA447247 | liver transplantation |
PA151958383 | Gastrointestinal Stromal Tumors |
PA446171 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
PA446108 | Colorectal Neoplasms |
PA133888799 | Organ Transplantation |
PA443265 | Adenocarcinoma |
PA443557 | Brain Neoplasms |
PA443756 | Colonic Neoplasms |
PA444840 | Lymphoma |
PA444903 | Melanoma |
PA445204 | Ovarian Neoplasms |
PA445425 | Prostatic Neoplasms |
PA447230 | HIV |
PA443523 | Blood Coagulation Disorders |
PA445083 | Nephritis, Interstitial |
PA444447 | Carcinoma, Hepatocellular |
PA133888799 | Organ Transplantation |
PA134850491 | Transplantation |
PA443340 | Anemia |
PA444773 | Leukopenia |
PA445846 | Thrombocytopenia |
PA446975 | Neurotoxicity Syndromes |
PA445742 | Stomach Neoplasms |
Releated drug ID | Related drug Name |
---|---|
PA152207466 | farnesyltransferase inhibitors |
PA165110778 | Tipifarnib |
PA164713176 | Platinum compounds |
PA449412 | doxorubicin |
PA449943 | hydroxyzine |
PA450704 | omeprazole |
PA448015 | acetaminophen |
PA449686 | fluticasone propionate |
PA450530 | modafinil |
PA10075 | esomeprazole |
PA450546 | montelukast |
PA451257 | risperidone |
PA451344 | sibutramine |
PA451866 | venlafaxine |
PA448383 | amiodarone |
PA451333 | sertraline |
PA449035 | clindamycin |
PA450741 | oxycodone |
PA451746 | tretinoin |
PA450344 | medroxyprogesterone |
PA451201 | quetiapine |
PA451123 | progesterone |
PA130232992 | bevacizumab |
PA128406956 | fluorouracil |
PA131285527 | oxaliplatin |
PA164746311 | everolimus |
PA165260403 | arteether |
PA165111698 | artemether |
PA165111696 | artemisinin |
PA165111697 | artesunate |
PA450947 | phenytoin |
PA451753 | triazolam |
PA450631 | nifedipine |
PA451627 | testosterone |
PA448689 | buspirone |
PA449594 | fenofibrate |
PA450353 | meloxicam |
PA449918 | hydromorphone |
PA449028 | clarithromycin |
PA451974 | ziprasidone |
PA451744 | trazodone |
PA451612 | terazosin |
PA450128 | isotretinoin |
PA451976 | zolpidem |
PA449493 | erythromycin |
PA162630444 | eszopiclone |
PA449160 | cyclobenzaprine |
PA450970 | pioglitazone |
PA449394 | donepezil |
PA10074 | escitalopram |
PA448960 | chlorpheniramine |
PA449015 | citalopram |
PA450522 | mirtazapine |
PA449527 | ethinyl estradiol |
PA10333 | tadalafil |
PA448385 | amitriptyline |
PA449599 | fentanyl |
PA449900 | hydrocodone |
PA451346 | sildenafil |
PA451735 | tramadol |
PA451142 | propoxyphene |
PA449283 | diazepam |
PA451583 | tamsulosin |
PA448871 | celecoxib |
PA449841 | haloperidol |
PA450369 | meperidine |
PA450266 | loratadine |
PA450268 | losartan |
PA448685 | buprenorphine |
PA451300 | salmeterol |
PA451668 | thiotepa |
PA450272 | lovastatin |
PA449673 | fluoxetine |
PA448785 | carbamazepine |
PA448333 | alprazolam |
PA449688 | fluvastatin |
PA133950441 | hmg coa reductase inhibitors |
PA451089 | pravastatin |
PA134308647 | rosuvastatin |
PA449383 | docetaxel |
PA10832 | corticosteroids |
PA450566 | mycophenolate mofetil |
PA452609 | aflatoxin b1 |
PA450262 | loperamide |
PA451627 | testosterone |
PA164746334 | cilostazol |
PA448803 | carboplatin |
PA451581 | tamoxifen |
PA451213 | quinine |
PA451899 | vitamin d and analogues |
PA451611 | teniposide |
PA130620651 | anthracyclines and related substances |
PA450401 | methadone |
PA448388 | amlodipine |
PA451365 | sirolimus |
PA452620 | tegafur |
PA449167 | cyclosporine |
PA452609 | aflatoxin b1 |
PA451363 | simvastatin |
PA451868 | verapamil |
PA131301952 | gefitinib |
PA449512 | estrone |
PA450180 | lansoprazole |
PA450774 | pantoprazole |
PA451216 | rabeprazole |
PA450264 | lopinavir |
PA451260 | ritonavir |
PA449319 | digoxin |
PA449653 | fluconazole |
PA448500 | atorvastatin |
PA452233 | antipsychotics |
PA448681 | budesonide |
PA451305 | saquinavir |
PA10804 | imatinib |
PA450761 | paclitaxel |
PA448492 | asparaginase |
PA449177 | cytarabine |
PA449212 | daunorubicin |
PA449247 | dexamethasone |
PA449552 | etoposide |
PA450198 | leucovorin |
PA450379 | mercaptopurine |
PA450428 | methotrexate |
PA451100 | prednisone |
PA451879 | vincristine |
PA451578 | tacrolimus |
PA448084 | alfentanil |
PA449165 | cyclophosphamide |
PA452621 | antineoplastic agents |
PA450085 | irinotecan |
PA449053 | clopidogrel |
PA450496 | midazolam |
PA452604 | xenobiotics |
PA449011 | cisapride |
PA449977 | indinavir |
PA450616 | nevirapine |
PA452347 | glucocorticoids |
PA451906 | warfarin |
PA165290926 | fluticasone/salmeterol |
PA449334 | diltiazem |
PA164712468 | Antimalarials |
PA449167 | cyclosporine |
PA449957 | ibuprofen |
No data |
Drugbank ID | Action | Drug Name | Description |
---|---|---|---|
DB00091 | inducer | Cyclosporine | Antirheumatic Agents;Immunomodulatory Agents;Enzyme Inhibitors;Dermatologic Agents;Immunosuppressive Agents;Antifungal Agents |
DB00175 | substrate | Pravastatin | Anticholesteremic Agents;HMG-CoA Reductase Inhibitors;Hydroxymethylglutaryl-CoA Reductase Inhibitors |
DB00176 | inhibitor | Fluvoxamine | Anti-anxiety Agents;Selective Serotonin Reuptake Inhibitors (SSRIs);Antidepressive Agents;Serotonin Uptake Inhibitors;Antidepressive Agents, Second-Generation |
DB00196 | inhibitor | Fluconazole | Antifungals;Antifungal Agents |
DB00197 | inducer | Troglitazone | Antineoplastic Agents;Hypoglycemic Agents;Vasodilator Agents;Platelet Aggregation Inhibitors;Fibrinolytic Agents |
DB00199 | inhibitor | T-Stat Pad-Lot | Anti-Bacterial Agents;Macrolides |
DB00201 | substrate | Wigraine Tab | Central Nervous System Stimulants;Anorexigenic Agents;Phosphodiesterase Inhibitors |
DB00203 | substrate | Sildenafil | Vasodilator Agents;Phosphodiesterase Inhibitors |
DB00206 | inducer | SER-AP-ES Tab | Antihypertensive Agents;Adrenergic Uptake Inhibitors;Antipsychotics;Peripheral Adrenergic Inhibitors;Antipsychotic Agents |
DB00220 | inhibitor | Nelfinavir | Anti-HIV Agents;HIV Protease Inhibitors |
DB00224 | inhibitor | Indinavir | Anti-HIV Agents;HIV Protease Inhibitors |
DB00227 | substrate | Lovastatin | Antineoplastic Agents;Anticholesteremic Agents;HMG-CoA Reductase Inhibitors;Hydroxymethylglutaryl-CoA Reductase Inhibitors |
DB00238 | substrate | Nevirapine | Anti-HIV Agents;Nonnucleoside Reverse Transcriptase Inhibitors;Reverse Transcriptase Inhibitors |
DB00246 | substrate | Ziprasidone | Antipsychotics;Dopamine Antagonists;Serotonin Antagonists;Antipsychotic Agents |
DB00250 | substrate | Dapsone | Anti-Infective Agents;Anti-Infectives;Anti-inflammatory Agents;Antimalarials;Folic Acid Antagonists;Leprostatic Agents;Antimycobacterials |
DB00252 | inducer | Dilantin W Phenobarbital 30mg Cap | Anticonvulsants |
DB00278 | substrate | Argatroban | Anticoagulants;Platelet Aggregation Inhibitors |
DB00281 | substrate | Xylonor Spray | Antiarrhythmic Agents;Anesthetics;Anesthetics, Local;Anti-Arrhythmia Agents |
DB00313 | substrate | Valproic Acid | Anticonvulsants;Enzyme Inhibitors;Antimanic Agents;GABA Agents |
DB00318 | substrate | Co-codamol | Narcotics;Analgesics;Opiate Agonists;Antitussives;Analgesics, Opioid;Antitussive Agents |
DB00321 | substrate | Triavil Tab | Adrenergic Uptake Inhibitors;Analgesics, Non-Narcotic;Antidepressive Agents, Tricyclic |
DB00333 | substrate | Methadone | Narcotics;Analgesics;Opiate Agonists;Antitussives;Analgesics, Opioid;Antitussive Agents |
DB00342 | substrate | Terfenadine | Antiarrhythmic Agents;Anti-Allergic Agents;Antihistamines;Histamine H1 Antagonists, Non-Sedating |
DB00343 | inhibitor | Diltiazem | Antihypertensive Agents;Vasodilator Agents;Calcium Channel Blockers;Cardiovascular Agents |
DB00381 | substrate | Lotrel | Antihypertensive Agents;Vasodilator Agents;Calcium Channel Blockers;Antianginals |
DB00393 | substrate | Nimodipine | Antihypertensive Agents;Vasodilator Agents;Calcium Channel Blockers |
DB00394 | inducer | Beclomethasone | Anti-Asthmatic Agents;Anti-inflammatory Agents;Antiarrhythmic Agents;Corticosteroids;Glucocorticoids |
DB00396 | substrate | Synovex S | Contraceptives;Progestins |
DB00398 | substrate | Sorafenib | Antineoplastic Agents;Protein Kinase Inhibitors;Anticancer Agents |
DB00401 | substrate | Nisoldipine | Antihypertensive Agents;Vasodilator Agents;Calcium Channel Blockers |
DB00404 | substrate | Alprazolam | Anti-anxiety Agents;Hypnotics and Sedatives;Benzodiazepines;GABA Modulators |
DB00425 | substrate | Zolpidem | GABA Agonists;Hypnotics and Sedatives |
DB00439 | substrate | Cerivastatin | Anticholesteremic Agents;Antilipemic Agents;Hydroxymethylglutaryl-CoA Reductase Inhibitors |
DB00444 | substrate | Teniposide | Antineoplastic Agents;Enzyme Inhibitors;Nucleic Acid Synthesis Inhibitors |
DB00446 | inhibitor | Zoomycetine Spray | Anti-Bacterial Agents;Protein Synthesis Inhibitors |
DB00468 | substrate | Triogene for | Antimalarials;Analgesics, Non-Narcotic;Muscle Relaxants, Central |
DB00490 | substrate | Buspirone | Anti-anxiety Agents;Serotonin Agonists;Anxiolytics sedatives and hypnotics |
DB00497 | substrate | Tylox | Narcotics;Opiate Agonists;Antitussives;Analgesics, Opioid |
DB00499 | substrate | Flutamide | Antineoplastic Agents, Hormonal;Androgen Antagonists |
DB00501 | inhibitor | Cimetidine | Anti-Ulcer Agents;Analgesics;Enzyme Inhibitors;Adjuvants;Histamine Antagonists;Histamine H2 Antagonists |
DB00502 | substrate | Haloperidol | Antiemetics;Antidyskinetics;Antipsychotics;Dopamine Antagonists;Antipsychotic Agents;Butyrophenones;Anti-Dyskinesia Agents |
DB00503 | inhibitor | Kaletra | Anti-HIV Agents;HIV Protease Inhibitors |
DB00514 | substrate | Tussin Cough Medicine Dm Antitussive Expectorant Decongestant | Analgesics, Opioid;Antitussive Agents;Excitatory Amino Acid Antagonists |
DB00528 | substrate | Lercanidipine | Antihypertensive Agents;Calcium Channel Blockers |
DB00530 | substrate | Erlotinib | Protein Kinase Inhibitors |
DB00532 | - | Mephenytoin | Anticonvulsants |
DB00537 | inhibitor | Ciprodex | Anti-Infective Agents;Anti-Infectives;Quinolones;Nucleic Acid Synthesis Inhibitors |
DB00540 | substrate | Nortriptyline | Antidepressants;Adrenergic Uptake Inhibitors;Antidepressive Agents, Tricyclic;Norepinephrine-Reuptake Inhibitors |
DB00541 | substrate | Vincristine | Antineoplastic Agents;Antineoplastic Agents, Phytogenic;Tubulin Modulators |
DB00564 | inducer | Carbamazepine | Anticonvulsants;Analgesics;Antimanic Agents;Analgesics, Non-Narcotic |
DB00571 | substrate | Propranolol | Anti-anxiety Agents;Antihypertensive Agents;Adrenergic Agents;Adrenergic beta-Antagonists;Vasodilator Agents;Antiarrhythmic Agents;Anti-Arrhythmia Agents |
DB00582 | inhibitor | Voriconazole | Antifungals;Antifungal Agents |
DB00588 | inhibitor | Fluticasone Propionate | Anti-inflammatory Agents;Adrenergic Agents;Dermatologic Agents;Bronchodilator Agents;Anti-Allergic Agents |
DB00593 | substrate | Ethosuximide | Anticonvulsants;Succinimides |
DB00604 | substrate | Cisapride | Anti-Ulcer Agents;Gastrointestinal Agents;Serotonin Agonists;Prokinetic Agents |
DB00608 | substrate | Chloroquine | Antirheumatic Agents;Antimalarials;Amebicides |
DB00619 | inhibitor | Imatinib | Antineoplastic Agents;Protein Kinase Inhibitors |
DB00622 | inhibitor | Nicardipine | Antihypertensive Agents;Vasodilator Agents;Antiarrhythmic Agents;Calcium Channel Blockers;Dihydropyridines |
DB00624 | substrate | Uni-Bol | Androgens |
DB00637 | substrate | Astemizole | Anti-Allergic Agents;Antihistamines;Histamine H1 Antagonists, Non-Sedating |
DB00641 | substrate | Vytorin | Anticholesteremic Agents;Antilipemic Agents;Hydroxymethylglutaryl-CoA Reductase Inhibitors |
DB00655 | substrate | Holis 98 | Antineoplastic Agents;Estrogens;Osteoporosis Prophylactic;Anti-menopausal Agents |
DB00656 | substrate | Trazodone | Anti-anxiety Agents;Antidepressants, Second-Generation;Serotonin Uptake Inhibitors;Antidepressive Agents, Second-Generation |
DB00661 | inhibitor | Tarka | Vasodilator Agents;Antiarrhythmic Agents;Calcium Channel Blockers;Anti-Arrhythmia Agents |
DB00673 | inhibitor | Aprepitant | Antiemetics |
DB00675 | substrate | Tamoxifen | Antineoplastic Agents, Hormonal;Selective Estrogen Receptor Modulators;Estrogen Antagonists;Bone Density Conservation Agents |
DB00678 | substrate | Hyzaar | Antihypertensive Agents;Angiotensin II Receptor Antagonists;Antiarrhythmic Agents;Angiotensin II Type 1 Receptor Blockers;Anti-Arrhythmia Agents |
DB00683 | substrate | Midazolam | Anti-anxiety Agents;Hypnotics and Sedatives;Adjuvants, Anesthesia;GABA Modulators;Anesthetics, Intravenous |
DB00694 | - | Daunorubicin | Antineoplastic Agents;Antibiotics;Antibiotics, Antineoplastic |
DB00700 | substrate | Eplerenone | Antihypertensive Agents;Aldosterone Antagonists |
DB00701 | substrate | Amprenavir | Anti-HIV Agents;HIV Protease Inhibitors;Antibiotics, Antitubercular |
DB00705 | inhibitor | Delavirdine | Anti-HIV Agents;Nonnucleoside Reverse Transcriptase Inhibitors;Reverse Transcriptase Inhibitors |
DB00717 | substrate | Synphasic (28 day) | Contraceptives, Oral, Synthetic;Progestins |
DB00731 | substrate | Nateglinide | Hypoglycemic Agents;Meglitinides |
DB00734 | substrate | Risperidone | Antipsychotics;Dopamine Antagonists;Serotonin Antagonists;Antipsychotic Agents |
DB00738 | substrate | Pentamidine | Antifungal Agents;Trypanocidal Agents;Antiprotozoal Agents |
DB00741 | substrate | Vosol Hc | Anti-inflammatory Agents |
DB00745 | inducer | Modafinil | Central Nervous System Stimulants;Central Nervous System Agents;Anorexigenic Agents;Stimulants;Neuroprotective Agents |
DB00755 | substrate | Tretinoin | Antineoplastic Agents;Keratolytic Agents;Cell Stimulants and Proliferants |
DB00758 | substrate | Clopidogrel | Antiplatelet Agents;Platelet Aggregation Inhibitors;Fibrinolytic Agents |
DB00762 | substrate | Irinotecan | Antineoplastic Agents;Radiation-Sensitizing Agents;Parasympathomimetics;Enzyme Inhibitors;Prodrugs;Antineoplastic Agents, Phytogenic |
DB00773 | inducer | Etoposide | Nucleic Acid Synthesis Inhibitors;Antineoplastic Agents, Phytogenic |
DB00776 | inducer | Oxcarbazepine | Anticonvulsants |
DB00780 | inhibitor | Phenelzine | Antidepressants;Antidepressive Agents;Monoamine Oxidase Inhibitors |
DB00783 | substrate | Triquilar 21 | Anticholesteremic Agents;Estrogens;Anti-menopausal Agents |
DB00795 | substrate | Sulfasalazine | Antirheumatic Agents;Anti-Infective Agents;Sulfonamides;Gastrointestinal Agents |
DB00802 | substrate | Alfentanil | Narcotics;Analgesics;Anesthetics;Anesthetics, Intravenous;Opiate Agonists;Analgesics, Opioid |
DB00813 | substrate | Innovar Injection | Narcotics;Analgesics;Adjuvants, Anesthesia;Anesthetics;Anesthetics, Intravenous;Opiate Agonists;Analgesics, Opioid;Adjuvants |
DB00822 | substrate | Disulfiram | Enzyme Inhibitors;Alcohol Deterrents |
DB00829 | substrate | Diazepam | Anti-anxiety Agents;Hypnotics and Sedatives;Antiemetics;Anticonvulsants;Adjuvants, Anesthesia;GABA Modulators;Anesthetics, Intravenous;Muscle Relaxants, Central |
DB00834 | inhibitor | Mifepristone | Contraceptives, Oral, Synthetic;Menstruation-Inducing Agents;Luteolytic Agents;Contraceptives, Postcoital, Synthetic;Hormone Antagonists;Abortifacient Agents, Steroidal |
DB00842 | substrate | Oxazepam | Anti-anxiety Agents;Hypnotics and Sedatives;GABA Modulators |
DB00862 | substrate | Vardenafil | Vasoconstrictor Agents;Phosphodiesterase Inhibitors;Anti-Impotence Agents |
DB00863 | inhibitor | Tritec | Anti-Ulcer Agents;Histamine H2 Antagonists |
DB00864 | substrate | Tacrolimus | Immunosuppressive Agents |
DB00877 | substrate | Sirolimus | Anti-Bacterial Agents;Antifungals;Immunosuppressive Agents;Antifungal Agents;Antibiotics, Antineoplastic;Macrolides |
DB00889 | substrate | Granisetron | Antiemetics;Serotonin Antagonists |
DB00897 | substrate | Triazolam | Anti-anxiety Agents;Benzodiazepines;Adjuvants, Anesthesia;GABA Modulators |
DB00904 | substrate | Ondansetron | Anti-anxiety Agents;Antiemetics;Antipsychotics;Serotonin Antagonists;Antipruritics;Antipsychotic Agents |
DB00907 | substrate | Cocaine | Vasoconstrictor Agents;Dopamine Uptake Inhibitors;Anesthetics;Local Anesthetics;Anesthetics, Local |
DB00921 | substrate | Buprenorphine | Narcotics;Analgesics, Opioid;Narcotic Antagonists |
DB00938 | substrate | Advair 500 Diskus | Bronchodilator Agents;Adrenergic beta-Agonists;Sympathomimetic |
DB00943 | substrate | Zalcitabine | Anti-HIV Agents;Antimetabolites;Nucleoside and Nucleotide Reverse Transcriptase Inhibitors;Reverse Transcriptase Inhibitors |
DB00962 | substrate | Zaleplon | Hypnotics and Sedatives;Anticonvulsants;Anxiolytics sedatives and hypnotics |
DB00972 | substrate | Azelastine | Lipoxygenase Inhibitors;Platelet Aggregation Inhibitors;Bronchodilator Agents;Anti-Allergic Agents;Histamine H1 Antagonists;Histamine H1 Antagonists, Non-Sedating |
DB00976 | inhibitor | Telithromycin | Anti-Bacterial Agents;Ketolides |
DB01023 | substrate | Lexxel | Antihypertensive Agents;Vasodilator Agents;Calcium Channel Blockers;Dihydropyridines |
DB01026 | inhibitor | Ketoconazole | Antifungals;Antifungal Agents |
DB01041 | inducer | Thalidomide | Immunosuppressive Agents;Leprostatic Agents;Teratogens;Angiogenesis Inhibitors |
DB01045 | inducer | Rifater | Enzyme Inhibitors;Antituberculosis Agents;Nucleic Acid Synthesis Inhibitors;Leprostatic Agents;Antibiotics;Antibiotics, Antitubercular |
DB01054 | substrate | Nitrendipine | Antihypertensive Agents;Vasodilator Agents;Calcium Channel Blockers |
DB01058 | substrate | Drontal Tab | Anthelmintics |
DB01059 | inhibitor | Norfloxacin | Anti-Infectives;Anti-Bacterial Agents;Enzyme Inhibitors;Quinolones;Nucleic Acid Synthesis Inhibitors |
DB01062 | substrate | Oxybutynin | Muscarinic Antagonists;Antispasmodics;Anticholinergic Agents;Parasympatholytics;Genitourinary Smooth Muscle Relaxants |
DB01076 | substrate | Caduet | Anticholesteremic Agents;HMG-CoA Reductase Inhibitors;Hydroxymethylglutaryl-CoA Reductase Inhibitors |
DB01098 | inhibitor | Rosuvastatin | Anticholesteremic Agents;HMG-CoA Reductase Inhibitors;Hydroxymethylglutaryl-CoA Reductase Inhibitors |
DB01100 | substrate | Pimozide | Dopamine Antagonists;Antipsychotic Agents;Anti-Dyskinesia Agents |
DB01103 | substrate | Quinacrine | Antineoplastic Agents;Enzyme Inhibitors;Antiprotozoals;Antimalarials;Anticestodal Agents;Antinematodal Agents;Antihelmintics |
DB01114 | substrate | Triaminicol Dm Syrup | Antipruritics;Anti-Allergic Agents;Histamine H1 Antagonists;Antihistamines |
DB01115 | substrate | Nifedipine | Vasodilator Agents;Calcium Channel Blockers;Tocolytic Agents;Dihydropyridines |
DB01118 | inhibitor | Amiodarone | Vasodilator Agents;Enzyme Inhibitors;Anti-Arrhythmia Agents |
DB01126 | substrate | Dutasteride | Enzyme Inhibitors;Anti-baldness Agents;Antihyperplasia Agents |
DB01149 | inhibitor | Nefazodone | Antidepressants;Analgesics;Antidepressive Agents, Second-Generation;Serotonin Agents |
DB01166 | substrate | Cilostazol | Vasodilator Agents;Platelet Aggregation Inhibitors;Fibrinolytic Agents;Phosphodiesterase Inhibitors;Bronchodilator Agents;Neuroprotective Agents |
DB01167 | inhibitor | Itraconazole | Antifungals;Antiprotozoals;Antifungal Agents;Antiprotozoal Agents |
DB01174 | inducer | Phenobarbital | Hypnotics and Sedatives;Anticonvulsants;GABA Modulators;Excitatory Amino Acid Antagonists |
DB01181 | substrate | Ifosfamide | Antineoplastic Agents;Immunosuppressive Agents;Antineoplastic Agents, Alkylating |
DB01184 | substrate | Domperidone | Antiemetics;Dopamine Antagonists |
DB01201 | inducer | Rifapentine | Leprostatic Agents;Antimycobacterials;Antibiotics, Antitubercular |
DB01211 | inhibitor | Clarithromycin | Anti-Bacterial Agents;Other Macrolides;Protein Synthesis Inhibitors;Macrolides |
DB01216 | substrate | Finasteride | Enzyme Inhibitors;Skin and Mucous Membrane Agents;Anti-baldness Agents;Antihyperplasia Agents |
DB01218 | substrate | Halofantrine | Antiprotozoals;Antimalarials |
DB01224 | substrate | Quetiapine | Antipsychotics;Antipsychotic Agents |
DB01227 | substrate | Levomethadyl Acetate | Narcotics;Analgesics, Opioid |
DB01229 | substrate | Paclitaxel | Antineoplastic Agents;Antineoplastic Agents, Phytogenic;Tubulin Modulators |
DB01232 | inhibitor | Saquinavir | Anti-HIV Agents;HIV Protease Inhibitors |
DB01234 | inducer | Tresaderm Dermatologic Solution | Anti-inflammatory Agents;Adrenergic Agents;Antiemetics;Antineoplastic Agents, Hormonal;Glucocorticoids |
DB01238 | substrate | Aripiprazole | Antipsychotics;Antipsychotic Agents |
DB01248 | substrate | Docetaxel | Antineoplastic Agents;Radiation-Sensitizing Agents;Antimalarials;Antineoplastic Agents, Phytogenic |
DB01254 | substrate | Dasatinib | Protein Kinase Inhibitors |
DB01259 | substrate | Lapatinib | Antineoplastic Agents;Protein Kinase Inhibitors |
DB01268 | substrate | Sunitinib | Antineoplastic Agents;Angiogenesis Inhibitors |
DB01361 | - | Troleandomycin | Anti-Bacterial Agents;Antibacterial Agents;Macrolides |
DB01388 | inhibitor | Mibefradil | Antihypertensive Agents;Vasodilator Agents;Calcium Channel Blockers |
DB06267 | substrate | Udenafil | Vasodilator Agents;Phosphodiesterase Inhibitors |
DB06287 | inhibitor | Temsirolimus | Antineoplastic Agents;Protein Kinase Inhibitors |
DB06335 | substrate | Saxagliptin | |
DB06697 | substrate | Riamet | Antimalarials;Antiprotozoal Agents;Antimalarial Agents |
DB06730 | inhibitor | Gestodene | |
DB06731 | inhibitor | Seproxetine | |
DB06772 | substrate | Cabazitaxel | Antineoplastic Agents;Anticancer Agents |
No data |
No data |